NHLBI Workshop summaryPathophysiology of severe asthma☆,☆☆,★
Section snippets
Background on severe asthma
Although asthma affects an increasing number of patients, the severity and chronicity of this disease can vary considerably. In categorizing the severity of asthma, many factors need to be considered (Table I).
1. Symptoms Exacerbations •Frequency •Severity 2. Medication use Response to treatment or intensity of treatment required to control symptoms 3. Pulmonary functions 4. Bronchial responsiveness 5. Airway inflammation 6. Development of airway remodeling
Epidemiology of asthma
Predictors of asthma severity may include disease duration, female gender, African American race, level of lung function, and degree of allergy. Although the need for hospitalization is also used, it may not be an accurate reflection of severe asthma because the threshold for this intervention is highly variable. Additional results suggest that it was inappropriate to equate control of asthma with disease severity and to measure health care utilization as a feature of severity. Symptoms may
Pathology of severe asthma
The European Network for Understanding Mechanisms of Severe Asthma (ENFUMOSA) is a multicenter cross-sectional project including 13 centers in 9 European countries in which approximately 150 patients with severe and an equal number of patients with well-controlled asthma as a comparison group were recruited. Patients with brittle asthma were considered as a separate well-defined group. The patients with chronic severe asthma had several interesting characteristics that separated them from those
Is severe asthma one disease or several?
Asthma is defined and diagnosed by a combination of clinical symptoms and physiologic abnormalities without reliance on pathologic/biologic markers. In fact, the physiologic definition of asthma is nonspecific, consisting of airflow limitation during expiration, which is variable and/or reversible to bronchodilators, in the presence of airway hyperresponsiveness. These definitions leave room for multiple pathologic processes to produce similar physiologic (and clinical) endpoints. Several lines
Genetics of asthma
Genetic studies of asthma and atopy have progressed rapidly during the past 5 years.19 Genome-wide screenings have been completed in 5 population samples identifying at least 19 regions that show evidence for linkage to asthma in multiple studies. This suggests that asthma per se is influenced by many genes, each with relatively small effects. Some candidate genes, such as IL13, CD14, and IL4RA, have also been associated with asthma or atopy in multiple studies, suggesting that these genes may
Inflammatory factors
The inflammatory processes in asthma are influenced by many factors including the generation of cytokines. With the use of bronchoscopy, biopsy, and lavage, a number of proinflammatory cytokines have been associated with the severity of disease process including the novel cytokines IL-9 and IL-11. These cytokines have been found to be increased in relationship to the disease severity. This contrasts to the presence of other cytokines (ie, IL-4 and IL-5), which may relate to general components
Pulmonary physiology
Severe asthma may be defined not only by difficult-to-control airway disease symptoms but also by the severity of abnormalities and measurements of pulmonary function. Careful physiologic characterizations of patients with well-defined severe asthma are lacking. In experiments performed in patients with more severe disease who exhibit nocturnal worsening of the disease, measurements of peripheral airway resistance (Rp) have been performed. These results clearly demonstrate that in patients with
Discussion
There was unanimous opinion that the study of severe asthma is a critical issue and important for study. Currently in the United States, this problem is greatly understudied. It was the opinion of the workshop participants that it is unlikely that any one center would have enough subjects to conduct meaningful studies. Therefore a cooperative-approach arrangement should be considered for success of this study. The centers should be skilled in the conduct and performance of bronchial lavage and
Recommendations for future directions
As a result of the workshop, together with the experiences gained from the study of severe asthma by the ENFUMOSA, the following recommendations were formulated for future research directions:
- 1.
Establish a uniform working definition of severe asthma to promote a reproducible classification system.
- 2.
Assemble a national cohort of patients with severe asthma that can be studied extensively to characterize the clinical, physiologic, radiologic, genetic, pathologic, histologic, and anatomic features of
References (53)
- et al.
Observations on emerging patterns of asthma in our society
J Allergy Clin Immunol
(1999) - et al.
Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma
J Allergy Clin Immunol
(1998) - et al.
A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma
J Allergy Clin Immunol
(1996) - et al.
Characteristics of asthma among elderly adults in a sample of the general population
Chest
(1991) - et al.
Genetics of asthma
J Allergy Clin Immunol
(1999) - et al.
The impact of respiratory infections on asthma
- et al.
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
Lancet
(1999) Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
Ann Allergy Asthma Immunol
(1999)- et al.
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
J Allergy Clin Immunol
(2000) - et al.
Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform
J Allergy Clin Immunol
(2000)
Increased number of glucocorticoid receptor-β–expressing cells in the airways in fatal asthma
J Allergy Clin Immunol
Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography
Lancet
Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations
Am J Hum Genet
The R576 IL-4 receptor α allele correlates with asthma severity
J Allergy Clin Immunol
Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma
Am J Med
Epidemiology of asthma
Allergy
Difficult asthma [review]
Eur Respir J
The costs of asthma
Eur Respir J
Guidelines for the diagnosis and management of asthma. Expert panel report 2
Severe asthma: defining, diagnosing, and treating
J Respir Dis
Proceedings of the ATS Workshop on Refractory Asthma: current understanding, recommendations and unanswered questions
Am J Respir Crit Care Med.
Prospective study of hospitalization for asthma—a preliminary risk factor model
Am J Respir Crit Care Med
Brittle asthma
Thorax
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
Am J Respir Crit Care Med
Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study
Ann Intern Med
Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
Am J Respir Crit Care Med
Cited by (196)
Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015
2023, World Allergy Organization JournalELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice
2023, Journal of Allergy and Clinical ImmunologyAsthma and COPD: distinct diseases or components of a continuum?
2023, Asthma in the 21st Century: New Research AdvancesLongitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses
2021, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Because severe asthmatics with uncontrolled eosinophilic airway inflammation suffered from frequent SAEs that accelerated lung function declines, more active interventions, such as biologics targeting type 2 inflammation, are required to prevent SAEs and lung function declines in severe asthmatics.26,27 Eosinophilic airway inflammation is major pathophysiology of severe asthma.28,29 Blood eosinophil count has been widely used as a useful biomarker for eosinophilic airway inflammation, and its clinical implications have been reported in the clinical studies.30-32
The genetics of asthma and the promise of genomics-guided drug target discovery
2020, The Lancet Respiratory Medicine
- ☆
Workshop supported by the Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, May 11-12, 2000.
- ☆☆
Workshop participants: Jack A. Elias, MD, John Fahy, MD, Allison D. Fryer, PhD, Warren B. Gefter, MD, Stephen Holgate, MD, DSc, Charles G. Irvin, PhD, Nizar N. Jarjour, MD, Robert F. Lemanske, Jr, MD, Donald Y. M. Leung, MD, PhD, Craig M. Lilly, MD, Richard Martin, MD, Fernando D. Martinez, MD, Patricia Noel, PhD, Carole Ober, PhD, Reynold A.Panettieri, Jr, MD, Stephen P. Peters, MD, PhD, Thomas A. Platts-Mills, MD, Scott T. Weiss, MD, and Rosalind J. Wright, MD.
- ★
Reprint requests: Susan Banks-Schlegel, PhD, Division of Lung Diseases, National Heart, Lung, and Blood Institute, 2 Rockledge Center, Suite 10018, 6701 Rockledge Dr, MSC 7952, Bethesda, MD 20892-7952.